New biologic aortic valve replacement study
Part of Genetic & congenital, Heart & circulation clinical trials.
This study is testing a new generation of biologic (tissue) replacement valves for the aortic valve in adults aged 18 to 65. It aims to see how well these newer devices work compared to standard options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are eligible for surgery to replace your aortic valve (the main heart valve that sends blood to your body) with a biologic valve (made from tissue).
- This includes replacing your own valve or replacing an existing artificial biologic valve.
- You are not planning to get a mechanical (metal) valve.
- You do not need surgery on another heart valve or a catheter-based procedure (like TAVR).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to replace a narrowed heart valve in people with a bicuspid aortic valve. If you're 50 or older and need a new valve, this study can help figure out which approach works best.
This observational registry collects information about people who need an aortic valve replacement using a biologic (bioprosthesis) valve. It aims to better understand safety and effectiveness in everyday care, not to test a new drug or procedure.
This trial tests a new polymer heart valve for people with severe aortic valve narrowing or leakage. It aims to see if the valve is safe and works well as a replacement.
This study tests a biological (tissue) heart valve replacement system designed to be easier to change later. It may help people who need valve surgery because their valve is narrowed or damaged.
This trial tests how well a new replacement heart valve works and how safe it is. You might qualify if you need a planned first-time aortic valve replacement and are 60-70 years old (or younger if you cannot take blood thinners).
This trial tests a new type of aortic heart valve (PoliaValve) for people with severe aortic valve disease who need valve replacement surgery. If you qualify, you will receive the experimental valve and be followed for one year to see how well it works.
Hear when a new Aortic Regurgitation Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.